These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 14094765)

  • 41. [The effect of aspirin on the blood coagulation system of rheumatic children].
    Briazgunov IP
    Vopr Okhr Materin Det; 1966 Nov; 11(11):61-5. PubMed ID: 5996732
    [No Abstract]   [Full Text] [Related]  

  • 42. [RESEARCH ON THE PATHOGENESIS OF EXPERIMENTAL ENDOCARDITIS].
    CIOBANU V; STOICHITA M; GHEORGHIU M; OPRESCU CC
    Med Interna (Bucur); 1964 Jun; 16():665-9. PubMed ID: 14170448
    [No Abstract]   [Full Text] [Related]  

  • 43. Effects of intravenous injections of the anticoagulant fraction of incubated fibrinogen on blood coagulation.
    TRIANTAPHYLLOPOULOS DC
    Can J Biochem Physiol; 1960 Aug; 38():909-18. PubMed ID: 13839325
    [No Abstract]   [Full Text] [Related]  

  • 44. SURFACE FACTOR MECHANISMS IN RELATION TO BLOOD PLATELETS: EVIDENCE THAT ACTIVATED HAGEMAN FACTOR IS PRESENT ON THE SURFACE OF PLATELETS.
    IATRIDIS PG; FERGUSON JH; IATRIDIS SG
    Thromb Diath Haemorrh; 1964 Jul; 11():355-71. PubMed ID: 14194111
    [No Abstract]   [Full Text] [Related]  

  • 45. COAGULATION AND CLOT-LYSIS STUDIES IN GROUPS EATING HIGH AND LOW FAT DIETS. I. COMPARISON OF EAST AFRICANS WITH NEW YORKERS.
    LEE KT; KIM DN; SHAPER AG; THOMAS WA
    Exp Mol Pathol; 1964 Oct; 3():500-10. PubMed ID: 14225068
    [No Abstract]   [Full Text] [Related]  

  • 46. Action of trypsin:chymotrypsin (Chymoral forte DS) preparation on acute-phase proteins following burn injury in humans.
    Latha B; Ramakrishnan KM; Jayaraman V; Babu M
    Burns; 1997 Mar; 23 Suppl 1():S3-7. PubMed ID: 9177894
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of trypsin-chymotrypsin (Chymoral Forte D.S.) preparation on the modulation of cytokine levels in burn patients.
    RaviKumar T; Ramakrishnan M; Jayaraman V; Babu M
    Burns; 2001 Nov; 27(7):709-16. PubMed ID: 11600250
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [COAGULATION RESEARCH AND ITS CLINICAL SIGNIFICANCE].
    AMRIS CJ
    Manedsskr Prakt Laegegern; 1963 Dec; 41():484-503. PubMed ID: 14099118
    [No Abstract]   [Full Text] [Related]  

  • 49. [Morphological study of the blood platelets and of viscous metamorphosis using antifibrinogen and antiplatelet fluorescent antiserums].
    SOKAL G
    Acta Haematol; 1962; 28():313-25. PubMed ID: 13989901
    [No Abstract]   [Full Text] [Related]  

  • 50. [STATUS OF THE BLOOD COAGULATION SYSTEM AND THE USE OF ANTICOAGULANTS IN PATIENTS WITH STRANGULATED HERNIA].
    PAVLOVSKII DP
    Khirurgiia (Mosk); 1964 Feb; 40():145-52. PubMed ID: 14170172
    [No Abstract]   [Full Text] [Related]  

  • 51. [Influence of single and repeated hemodialises on the blood coagulation status].
    Albert FW; Kreiter H
    Munch Med Wochenschr; 1972 Nov; 114(44):1917-21. PubMed ID: 4678729
    [No Abstract]   [Full Text] [Related]  

  • 52. Association between standard laboratory and functional tests of coagulation in dilutional coagulopathy: an in vitro study.
    Krzych LJ; Czempik PF
    J Physiol Pharmacol; 2017 Aug; 68(4):637-645. PubMed ID: 29151081
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Experimental immune hemolysis and blood coagulation].
    Janzarik H; Köppler E; Lasch HG
    Thromb Diath Haemorrh; 1971 Aug; 26(1):22-8. PubMed ID: 5112375
    [No Abstract]   [Full Text] [Related]  

  • 54. Qualitative changes in fibrinogen which influence the erythrocyte sedimentation rate and the clot retraction time.
    MORRISON IR
    Am J Med Sci; 1946 Mar; 211():325-31. PubMed ID: 21017160
    [No Abstract]   [Full Text] [Related]  

  • 55. [Blood coagulation after radiotherapy of malignant gynecological tumors].
    Nagy I; Krommer K; Gáti I; Keller G
    Z Geburtshilfe Gynakol; 1970 Jun; 172(3):241-54. PubMed ID: 5516767
    [No Abstract]   [Full Text] [Related]  

  • 56. [Functional state of the anticoagulation system during intravenous administration of fibrin monomer].
    Kudriashov BA; Molchanova LV; Kalishevskaia TM; Bazaz'ian GG; Pastorova VE; Sytina NP
    Vopr Med Khim; 1969; 15(5):483-6. PubMed ID: 5368085
    [No Abstract]   [Full Text] [Related]  

  • 57. [ON BLOOD COAGULATION CHANGES AND THE ANTICOAGULANT EFFECT OF MONOAMINE OXIDASE INHIBITORS].
    HRDINA P; KOVALCIK V
    Cas Lek Cesk; 1963 May; 102():574-9. PubMed ID: 14051515
    [No Abstract]   [Full Text] [Related]  

  • 58. TURNOVER OF PROTHROMBIN AND FACTORS VII, IX AND X IN STATES OF HYPOCOAGULABILITY.
    HELLEMANS J; DEVREKER R; VORLAT M; VERSTRAETE M
    Acta Haematol; 1963 Jul; 30():35-41. PubMed ID: 14045902
    [No Abstract]   [Full Text] [Related]  

  • 59. The hypercoagulability in mercury chloride intoxicated dogs.
    Worowski K
    Thromb Diath Haemorrh; 1968 Mar; 19(1):236-41. PubMed ID: 5652230
    [No Abstract]   [Full Text] [Related]  

  • 60. [THROMBODENSITOGRAPHY. A METHOD OF DYNAMIC STUDY OF BLOOD COAGULATION].
    DINELLI CA; MONTANI E
    Omnia Med Ther; 1963; 41():123-206. PubMed ID: 14076800
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.